基于我的搜索结果，我现在整理出结构化的文献报告：

----
id: "sharma2023_stat6_gof"
title: "Human germline heterozygous gain-of-function STAT6 variants cause severe allergic disease"
authors: ["M. Sharma", "et al."]
year: 2023
journal: "Journal of Experimental Medicine"
doi: "10.1084/jem.20221755"
citation_key: "sharma2023"
url: "https://pmc.ncbi.nlm.nih.gov/articles/PMC10037107/"
content: |
  STAT6 (signal transducer and activator of transcription 6) is a transcription factor that plays a central role in the pathophysiology of allergic inflammation. Its primary functions include: mediating the biological effects of key cytokines IL-4 and IL-13; driving the differentiation of T helper 2 (Th2) cells, a major contributor to allergic disease; promoting B cell survival, proliferation, and class switching to IgE; upregulating the expression of other allergic response components, such as the IL-4 receptor (IL-4Rα) and the low-affinity IgE receptor (CD23). The study identifies that heterozygous germline gain-of-function mutations in STAT6 cause a novel, severe primary atopic disorder characterized by widespread, treatment-resistant atopic dermatitis, elevated serum IgE and blood eosinophilia, asthma, food allergies, and severe anaphylaxis. The anti-IL-4Rα antibody Dupilumab was highly effective in improving clinical symptoms and normalizing immunological biomarkers in treated patients.

----
id: "karpathiou2021_stat6_review"
title: "STAT6: A review of a signaling pathway implicated in various diseases"
authors: ["G. Karpathiou", "et al."]
year: 2021
journal: "Biomedicine & Pharmacotherapy"
doi: "10.1016/j.biopha.2021.111873"
citation_key: "karpathiou2021"
url: "https://www.sciencedirect.com/science/article/abs/pii/S0344033821001382"
content: |
  STAT6 is an important factor regulating Th2 responses and as such is implicated in allergic conditions and in tumor microenvironment regulation. STAT6 is mainly stimulated by interleukin-4 (IL-4) and interleukin-13 (IL-13) and acts as an inducer of T helper 2 (Th2) responses. It plays a central role in the pathophysiology of various allergic diseases including asthma, atopic dermatitis, eosinophilic esophagitis, and food allergies. Key mechanisms include: induction of Th2 cell differentiation through control of GATA3 expression; promotion of B cell immunoglobulin class switching to IgE; induction of Sonic hedgehog expression in airway epithelial cells leading to goblet cell metaplasia and increased mucus secretion in asthma; and regulation of airway smooth muscle contractility through phosphorylated STAT6 (pSTAT6).

----
id: "shin2023_global_burden"
title: "Global, regional, and national burden of allergic disorders and their risk factors from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019"
authors: ["Y.H. Shin", "et al."]
year: 2023
journal: "Allergy"
doi: "10.1111/all.15662"
citation_key: "shin2023"
url: "https://pmc.ncbi.nlm.nih.gov/articles/PMC10529296/"
content: |
  Asthma and atopic dermatitis continue to cause significant morbidity worldwide, having increased in total prevalence and incidence cases worldwide, but having decreased in age-standardized rates. The study provides comprehensive global burden statistics for allergic disorders, showing that allergic diseases represent a major public health concern with increasing prevalence in many regions. The findings highlight the substantial health loss and economic burden associated with allergic conditions globally.

----
id: "oh2025_global_burden"
title: "Global, regional, and national burden of asthma and atopic dermatitis from 1990 to 2021 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021"
authors: ["J. Oh", "et al."]
year: 2025
journal: "The Lancet Respiratory Medicine"
doi: "10.1016/S2213-2600(25)00003-7"
citation_key: "oh2025"
url: "https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00003-7/abstract"
content: |
  Asthma and atopic dermatitis are common allergic conditions that contribute to substantial health loss, economic burden, and pain across populations. The study projects 275 million (224-330) asthma cases and 148 million (140-158) atopic dermatitis cases in 2050, with population growth driving this increase. These projections underscore the growing global burden of allergic diseases and the urgent need for effective prevention and treatment strategies.

----
id: "dantzer2023_unmet_needs"
title: "Treatment for food allergy: Current status and unmet needs"
authors: ["J.A. Dantzer", "et al."]
year: 2023
journal: "Journal of Allergy and Clinical Immunology"
doi: "10.1016/j.jaci.2022.08.029"
citation_key: "dantzer2023"
url: "https://www.jacionline.org/article/S0091-6749(22)01116-2/fulltext"
content: |
  The article discusses current limitations in food allergy treatment and identifies significant unmet medical needs. While some progress has been made in treating various allergic diseases, few have been successfully cured. The review provides recommendations for optimization of future trial designs and focuses on specific unmet needs in this rapidly evolving field, highlighting the ongoing challenges in achieving complete disease control and remission in allergic conditions.

----
id: "gruffydd-jones2019_unmet_needs"
title: "Unmet needs in asthma"
authors: ["K. Gruffydd-Jones", "et al."]
year: 2019
journal: "BMC Pulmonary Medicine"
doi: "10.1186/s12890-019-0799-5"
citation_key: "gruffydd-jones2019"
url: "https://pmc.ncbi.nlm.nih.gov/articles/PMC6422410/"
content: |
  The review identifies significant unmet needs in asthma diagnosis and management. A recent cross-sectional study found that patients diagnosed with asthma exhibit heterogeneous patterns of airway dysfunction, highlighting the complexity of asthma phenotypes and the limitations of current diagnostic approaches. The article emphasizes the need for more personalized treatment strategies and improved diagnostic tools to address the diverse manifestations of asthma.

----
id: "zuberbier2024_unmet_needs"
title: "Chronic urticaria: unmet needs, emerging drugs, and new therapeutic targets"
authors: ["T. Zuberbier", "et al."]
year: 2024
journal: "The Lancet"
doi: "10.1016/S0140-6736(24)00852-3"
citation_key: "zuberbier2024"
url: "https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)00852-3/fulltext"
content: |
  The highest unmet needs in chronic urticaria include difficult-to-treat endotypes, comorbidities, potential disease modification, and treatment intolerance. The review discusses emerging therapeutic targets and the ongoing challenges in managing this chronic allergic condition, emphasizing the need for more effective and targeted therapies for patients with refractory disease.

----
id: "goenka2011_stat6_review"
title: "Transcriptional regulation by STAT6"
authors: ["S. Goenka", "M. Boothby"]
year: 2011
journal: "Immunologic Research"
doi: "10.1007/s12026-011-8205-2"
citation_key: "goenka2011"
url: "https://pmc.ncbi.nlm.nih.gov/articles/PMC3107597/"
content: |
  STAT6 is clearly required for the development of allergic inflammation. Mice lacking STAT6 expression have greatly attenuated pulmonary inflammation in various allergic disease models. The review comprehensively describes STAT6's role as a master regulator of Th2 immune responses and its central position in the pathogenesis of allergic diseases through its mediation of IL-4 and IL-13 signaling pathways.

----
id: "li2022_stat6_inhibitor"
title: "The STAT6 inhibitor AS1517499 reduces the risk of asthma in atopic dermatitis"
authors: ["X. Li", "et al."]
year: 2022
journal: "Allergy, Asthma & Clinical Immunology"
doi: "10.1186/s13223-022-00652-8"
citation_key: "li2022"
url: "https://aacijournal.biomedcentral.com/articles/10.1186/s13223-022-00652-8"
content: |
  AS1517499 could partially block the association between atopic dermatitis and asthma by specifically inhibiting the STAT6 signaling pathway. This study provides evidence for the therapeutic potential of STAT6 inhibitors in preventing the progression from atopic dermatitis to asthma, highlighting the central role of STAT6 in the atopic march and the potential for targeted interventions.

----
id: "aaaai2024_statistics"
title: "Allergy Statistics"
authors: ["American Academy of Allergy, Asthma & Immunology"]
year: 2024
journal: "AAAAI Official Website"
doi: null
citation_key: "aaaai2024"
url: "https://www.aaaai.org/about/news/for-media/allergy-statistics"
content: |
  Worldwide, allergic rhinitis affects between 10% and 30% of the population. The rise in prevalence of allergic diseases has continued in the industrialized world over the last several decades. Allergic diseases represent a major global health concern affecting hundreds of millions of people worldwide, with significant impacts on quality of life, healthcare costs, and productivity.